Related Experiment Video
Updated: Jun 2, 2025
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Prevalence of Pancreatic Steatosis in Inflammatory Bowel Disease Patients
Osman Cagin Buldukoglu1, Ahmet Sukru Alparslan2, Lutfullah Zahit Koc3
1Department of Gastroenterology, Antalya Training and Research Hospital, Antalya, Türkiye.
Objectives:
Inflammatory bowel diseases (IBD) are chronic, immune-mediated disorders of the gastrointestinal system. Pancreas can be affected in IBD patients with a wide array of clinical conditions including acu-te pancreatitis, abnormalities of pancreatic duct and pancreatic insufficiency. Pancreatic steatosis (PS) is an important but often overlooked pathology of pancreas. In this study, we aimed to investigate the prevalence of PS in IBD patients to reveal the possible association in between in a patient group already prone to pancreatic disease involvement.
Methods:
This retrospective study included 153 IBD patients who had a computed tomography scan in the last five years to evaluate the presence of PS. PS was defined as a pancreas/spleen attenuation ratio of below 0.70 in accordance with previous studies available in the literature. Demographic data, IBD subtype and treatment modality used for IBD were recorded and analyzed.
Results:
78 patients had Crohn's disease and 75 patients had ulcerative colitis. Presence of PS in IBD patients was 23.5%. Age and treatment modality were found to be related to PS presence. Logistic regression analysis revealed a statistically significant relationship between PS and advanced age (p=0.000) but not with treatment modality (p=0.290).
Conclusion:
PS is an important pathology of the pancreas with serious complications. In an already burdensome disease like IBD, PS can add more challenges to patient management. Although a direct correlation between PS and IBD prognosis is not established in current literature, evaluation of IBD patients for PS will help in prevention and management of PS-related conditions which will improve the overall well-being of IBD patients.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...